Home General Biotechnology Journal of Commercial Biotechnology — October 2008

Journal of Commercial Biotechnology — October 2008

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 14, Issue 4

Editorial

Continuing education in biotechnologyPDF
Yali Friedman

Articles

Can compliance help marketing and business development?PDF
John Avellanet
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiersPDF
Laura Heinonen, Birgitta Sandberg
Got value? Determine it. Demonstrate it. Communicate it. Realise itPDF
Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practicePDF
Kerstin M Bode-Greuel, Klaus J Nickisch

From the Classroom

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economiesPDF
Arlen D Meyers, Donald J McCubbrey, Richard T Watson

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: The Regulatory Challenge of BiotechnologyPDF
John Avellanet
Book Review: Intellectual Property and Biotechnology: Biological InventionsPDF
Stefan M Miller
Book Review: Commercializing Successful Biomedical TechnologiesPDF
Arlen D Meyers
Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the BiosciencesPDF
Arlen D Meyers
Best Practices in Biotechnology Business DevelopmentPDF
Hans-Erik Hamid Lydecker
Genetic Glass Ceilings: Transgenics for Crop BiodiversityPDF
Drew L Kershen
Biotechnology and the LawPDF
Edward L Korwek
Welcome to Biotech NationPDF
James Rogers

NO COMMENTS

Leave a Reply